反応式
ClC1C=CC(C([C:12]2[C:20]3[C:15](=[C:16]([CH2:22][S:23][CH3:24])[CH:17]=[C:18]([F:21])[CH:19]=3)[NH:14][CH:13]=2)CCO)=CC=1.[Cl:25][C:26]1[CH:31]=[CH:30][C:29]([CH:32]([C:34]2[CH:39]=[CH:38][C:37]([F:40])=[CH:36][CH:35]=2)O)=[C:28]([F:41])[CH:27]=1.FC1C=CC(C(C2C=CC(F)=CC=2)C2C3C(=C(CSC)C=CC=3)NC=2)=C(C)C=1>>[Cl:25][C:26]1[CH:31]=[CH:30][C:29]([CH:32]([C:34]2[CH:39]=[CH:38][C:37]([F:40])=[CH:36][CH:35]=2)[C:12]2[C:20]3[C:15](=[C:16]([CH2:22][S:23][CH3:24])[CH:17]=[C:18]([F:21])[CH:19]=3)[NH:14][CH:13]=2)=[C:28]([F:41])[CH:27]=1参加物
4
反応物 3
生成物 1
実験手順
The title compound was prepared starting from 500 mg (2.56 mmol) of the compound from Example 9 and 652 mg (2.56 mmol) of the compound from Example 85A in analogy to the synthesis of the compound from Example 101. 197 mg (18% of theory) of the target compound were obtained.
後処理
- custom197 mg (18% of theory) of the target compound were obtained
出典と根拠
- ORDレコード
- ord-5a3ea31910244963945cedb1786e2dda
- 出典データセット
- uspto-grants-2011_11
- 特許番号
- US08063234B2
関連ノート
読み込み中…